Ines Barrallo-Gonzalez - Publications

Enhancing precision oncology: the role of molecular tumor boards in early identification and targeted treatment of ESCAT II-III alterations.

Journal: ESMO open

Published: May 20, 2025

Systemic anticancer therapy near the end of life: an analysis of factors influencing treatment in advanced cancer patients.

Journal: ESMO open

Published: February 28, 2025

Relation between dabrafenib plus trametinib-induced pyrexia and age in BRAF V600-mutated metastatic melanoma patients: A post hoc analysis of the real-world ELDERLYMEL study.

Journal: Melanoma research

Published: February 07, 2025

Characteristics and outcomes of advanced melanoma patients with complete response and elective discontinuation of first-line anti-programmed death-1 monotherapy: A real-world multicentre observational cohort study.

Journal: Pigment cell & melanoma research

Published: November 27, 2022

SARS-CoV-2 infection in patients with melanoma: results of the Spanish Melanoma Group registry.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: August 28, 2022

Safety of combining dabrafenib plus trametinib in elderly BRAF V600 mutation-positive advanced melanoma patients: real-world data analysis of Spanish patients (ELDERLYMEL).

Journal: Melanoma research

Published: June 28, 2022

In the literature: February 2022.

Journal: ESMO open

Published: January 23, 2022

Molecular profiling of advanced solid tumours. The impact of experimental molecular-matched therapies on cancer patient outcomes in early-phase trials: the MAST study.

Journal: British journal of cancer

Published: April 04, 2021

In the literature: April 2021.

Journal: ESMO open

Published: March 16, 2021

A two-gene epigenetic signature for the prediction of response to neoadjuvant chemotherapy in triple-negative breast cancer patients.

Journal: Clinical epigenetics

Published: November 23, 2018